Key result
A Dysfunctional Adiposity Index (DAI) was associated with elevated HOMA-IR and values >1.065 independently predicted higher odds of diabetes, NAFLD, subclinical atherosclerosis, and hypertension.
Why the study?
Adipose tissue morpho-functionality evaluations predict cardiometabolic abnormalities better than standard adiposity measurements, motivating the development of a dysfunctional adiposity index based on these abnormalities.
Is the dysfunctional adiposity index (DAI) associated with early cardiometabolic abnormalities independently of adiposity and other risk factors in apparently healthy subjects?
Cross-Sectional (n=1,600)
Is the dysfunctional adiposity index (DAI) associated with early cardiometabolic abnormalities independently of adiposity and other risk factors in apparently healthy subjects?
Answers are grounded in this paper and cite their sources.
The dysfunctional adiposity index (DAI), calculated using accessible clinical parameters, serves as an early marker of adipose tissue abnormalities and cardiometabolic risk in apparently healthy subjects.
Compared to body mass index, waist circumference (WC), and adiposity measurements, adipose tissue (AT) morpho-functionality evaluations are better predictors of cardiometabolic abnormalities (CA). The present study establishes a dysfunctional adiposity index (DAI) as an early marker of CA based on adipocytes morpho-functional abnormalities. DAI was established in 340 subjects without cardiovascular risk factors selected from a cross-sectional study (n=1600). Then, DAI was calculated in 36 healthy subjects who underwent subcutaneous AT biopsy. The correlation of DAI with adipocyte morphology (size/number) and functionality (adiponectin/leptin ratio) was analyzed. The DAI cut-off point was identified and its independent association with CA was determined in 1418 subjects from the cross-sectional study. The constant parameters to calculate the DAI were [WC/[22.79+[2.68*BMI]]]*[triglycerides (TG, mmol/L)/1.37]*[1.19/high density lipoprotein-cholesterol (HDL-C, mmol/L)] for males, and [WC/[24.02+[2.37*BMI]]]*[TG(mmol/L)/1.32]*[1.43/HDL-C(mmol/L)] for females. DAI correlated with adipocytes mean area, adipocyte number and adiponectin/leptin ratio. DAI ≥1.065 was independently associated with diabetes, non-alcoholic fatty liver disease, subclinical atherosclerosis, and hypertension. The present study highlights that DAI is associated with early CA independently of adiposity and other risk factors. Since DAI is obtained using accessible parameters, it can be easily incorporated into clinical practice for early identification of AT abnormalities in apparently healthy subjects.
No takes yet. Share an insight, caveat, or question.
Reyes-Barrera et al. (2021) conducted a cross-sectional in Apparently healthy subjects (without cardiovascular disease) (n=1,600). Dysfunctional adiposity index (DAI) vs. Lower DAI values was evaluated on Elevated HOMA-IR (≥2.09) (AUC 0.743, p=0.017). A Dysfunctional Adiposity Index (DAI) was associated with elevated HOMA-IR and values >1.065 independently predicted higher odds of diabetes, NAFLD, subclinical atherosclerosis, and hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: